Thus, our interest focused on the detailed clinical course, including response to immunotherapy in addition to the expression of apoptosis-associated molecules Bcl-2 and Fas, Ki-67 cell proliferation activity, TUNEL apoptotic index in metastatic RCC, which remains not a rare clinical problem despite recent advances in diagnostic modalities and techniques. The gene discussed is FAS; the disease is renal cell adenocarcinoma.